ArticleFrontiers in neurology2020

Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials.

Marcello Moccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.